Derek Hei is currently the Chief Technology Officer at Kenai Therapeutics, where they focus on translating innovative biotherapeutics into early-stage human clinical trials. With extensive experience in manufacturing, quality control, and regulatory compliance, Derek has held senior leadership positions at companies such as Vertex Pharmaceuticals and BlueRock Therapeutics. They also serve as a member of the Board of Directors for WiCell and adjunct professor at the University of Wisconsin-Madison, teaching biotherapeutic development. Derek earned a PhD in Biochemical Engineering from the University of California, Berkeley, following a Bachelor's degree in Chemical Engineering from the University of Wisconsin-Madison.
This person is not in the org chart
This person is not in any offices